Lancaster Investment Management’s Moderna MRNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-46,500	Closed	-$5.52M	–	8
2024 Q2	$5.52M	Buy	+46,500	New	+$5.52M	3.61%	5